News All News

A research team out of Kit Parker’s lab at the John A. Paulson School of Engineering and Applied Sciences has developed a way to create customizable synthetic blood vessel grafts in minutes using a focused rotary jet spinning technology. The research has the potential to make time-sensitive medical treatments faster and more personalized.

Attivare, a startup advancing a portfolio of technologies developed at the Wyss Institute, John A. Paulson School of Engineering and Applied Sciences, Dana-Farber Cancer Institute, and Massachusetts General Hospital, has shown promising results in cancer clinical trials and is developing a malaria vaccine. Through decades of innovation and cross-disciplinary collaboration, the technology has the potential to fight cancer more effectively or prevent pathogen-related infections. 

Harvard University has expanded a research alliance agreement with Northpond Labs to fund translational research, accelerate commercialization, and advance breakthrough healthcare innovations across Harvard labs at the Wyss Institute, Harvard Medical School, John A. Paulson School of Engineering and Applied Sciences, and Faculty of Arts and Sciences.

A collaborative research team led by Mikhail Lukin, co-director of the Quantum Science and Engineering Initiative and a professor at the Harvard John A. Paulson School of Engineering and Applied Sciences, published research on a new system that addresses the challenge of quantum error correction. QuEra Computing, a startup company spun out of Lukin’s lab, is collaborating with the research team to advance these discoveries.